Good News For Some Hard-To-Treat Hepatitis C Patients

In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment. The findings, published in the June issue of Hepatology, offer a new option for hepatitis C patients, and may be effective even for those patients with factors that make their condition difficult to treat.

More: continued here

Filed under: Liver Disease / Hepatitis on June 22nd, 2009